Literature DB >> 2466835

Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy.

M Grootveld1, J D Bell, B Halliwell, O I Aruoma, A Bomford, P J Sadler.   

Abstract

The nature of non-transferrin-bound iron in the plasma or serum of iron-overloaded hemochromatosis patients was studied by high performance liquid chromatography (HPLC) and high resolution nuclear magnetic resonance (NMR). 500-MHz proton Hahn spin-echo NMR spectra of plasma or serum, combined with the use of the iron chelator desferrioxamine, suggests complexation of iron ions with citrate and a possible involvement of acetate. Addition of FeCl3 to hemochromatosis samples broadened the NMR signals from citrate. HPLC analysis rigorously confirmed the presence of an iron-citrate complex in ultrafiltrates of plasma or serum studies with added FeCl3 or desferrioxamine supported this conclusion. It is proposed that non-transferrin-bound iron in the plasma of iron-overloaded patients exists largely as complexes with citrate and possibly also as ternary iron-citrate-acetate complexes. The presence of such complexes would account for the ability of non-transferrin-bound iron to be measurable by the bleomycin assay and for its rapid clearance from the circulation by the liver.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466835

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  On the mechanism of citrate inhibition of ceruloplasmin ferroxidase activity.

Authors:  R A Løvstad
Journal:  Biometals       Date:  1996-07       Impact factor: 2.949

2.  Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.

Authors:  Louise de Swart; Jan C M Hendriks; Lisa N van der Vorm; Z Ioav Cabantchik; Patricia J Evans; Eldad A Hod; Gary M Brittenham; Yael Furman; Boguslaw Wojczyk; Mirian C H Janssen; John B Porter; Vera E J M Mattijssen; Bart J Biemond; Marius A MacKenzie; Raffaella Origa; Renzo Galanello; Robert C Hider; Dorine W Swinkels
Journal:  Haematologica       Date:  2015-09-18       Impact factor: 9.941

3.  Sequestration and scavenging of iron in infection.

Authors:  Nermi L Parrow; Robert E Fleming; Michael F Minnick
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

Review 4.  Iron transport proteins: Gateways of cellular and systemic iron homeostasis.

Authors:  Mitchell D Knutson
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

5.  Differing expression of genes involved in non-transferrin iron transport across plasma membrane in various cell types under iron deficiency and excess.

Authors:  Kamila Balusikova; Jitka Neubauerova; Marketa Dostalikova-Cimburova; Jiri Horak; Jan Kovar
Journal:  Mol Cell Biochem       Date:  2008-10-02       Impact factor: 3.396

Review 6.  Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis.

Authors:  B Halliwell
Journal:  Br J Exp Pathol       Date:  1989-12

7.  Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone.

Authors:  Patricia Evans; Reem Kayyali; Robert C Hider; John Eccleston; John B Porter
Journal:  Transl Res       Date:  2010-05-27       Impact factor: 7.012

8.  Involvement of polyamines in iron(III) transport in human intestinal Caco-2 cell lines.

Authors:  Gérard Lescoat; Lucie Gouffier; Isabelle Cannie; Olive Lowe; Isabelle Morel; Sylvie Lepage; Martine Ropert; Olivier Loréal; Pierre Brissot; François Gaboriau
Journal:  Mol Cell Biochem       Date:  2013-03-14       Impact factor: 3.396

9.  Angiotensin II promotes iron accumulation and depresses PGI₂ and NO synthesis in endothelial cells: effects of losartan and propranolol analogs.

Authors:  I Tong Mak; Kenneth M Landgraf; Joanna J Chmielinska; William B Weglicki
Journal:  Can J Physiol Pharmacol       Date:  2012-10-15       Impact factor: 2.273

10.  Differences in the uptake of iron from Fe(II) ascorbate and Fe(III) citrate by IEC-6 cells and the involvement of ferroportin/IREG-1/MTP-1/SLC40A1.

Authors:  Carla Thomas; Phillip S Oates
Journal:  Pflugers Arch       Date:  2004-04-28       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.